AstraZeneca (AZN -2.5%) will pay $520M to settle charges that it marketed its schizophrenia drug...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN -2.5%) will pay $520M to settle charges that it marketed its schizophrenia drug Seroquel for uses unapproved by the FDA - including for treatment of Alzheimer's disease, anxiety, dementia, depression and post-traumatic stress disorder - spurring unauthorized claims to pay for the drug.